Related Experiment Video
Updated: Jul 25, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Antiarrhythmic fatty acids and antioxidants in animal and cell studies
W R Leifert1, A Jahangiri, E J McMurchie
1Department of Physiology, University of Adelaide, Adelaide, SA, Australia.
Abstract:
From the animal and cellular studies that will be discussed in this review, it is apparent that dietary fatty acids and antioxidants play an important role in influencing the development of ventricular tachycardia and potentially lethal ventricular fibrillation. It is this latter disturbance to the rhythmic beating of the heart that is responsible for much of the mortality from coronary heart disease. It is now recognized that diets high in certain polyunsaturated fatty acids (PUFAs) and diets containing antioxidants can afford considerable protection to the heart with regard to the generation of disorders of contractile rhythmicity. The mechanism by which such dietary components confer their cardioprotective effects are now being intensively investigated, particularly with respect to their possible effects on the molecular mechanisms underlying the excitation-contraction coupling process of the myocardial cell. This overview will cover recent studies that have focused on the antiarrhythmic role of PUFAs, particularly those of the n-3 (or omega 3) class with emphasis on experiments performed using laboratory animals, isolated heart preparations, and isolated heart cells (cardiomyocytes). The role of free radicals (reactive oxygen species) and antioxidants in disorders of cardiac rhythm also will be addressed within the perspective of reperfusion injury to the myocardium following ischemia. Emphasis will be placed on the cardioprotective role of nutritional factors and components and the possible cellular mechanisms by which such components may act.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
08:05Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Atherosclerosis III: Management